Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7901–7950 of 35180
Dr. Swaminathan was also appointed to the Company’s Board as a Class III director to serve until the Company’s 2025 annual meeting of stockholders
On August 16, 2024, the Board of Directors (the “Board”) of Cohen & Steers, Inc. (the “Company”) appointed Lisa Dolly as a director of the Company and as a member of the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective immediately.
On the same date, Ms. Susie Giordano was appointed as a Class III director by the Board to fill the vacancy on the Board resulting from the increase in the authorized number of directors to nine (9), with her term expiring at the Company’s annual meeting of stockholders following fiscal year 2024.
On August 16, 2024, the Board of Directors (the “ Board ”) of Maplebear Inc. (the “ Company ”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, expanded the size of the Board from eight to nine directors and appointed Mary Beth Laughton as a Class I director, effective immediately.
On August 19, 2024, the Board of Directors (the “Board”) of AdvanSix Inc. (the “Company”) appointed Donald P. Newman to the Board, effective immediately.
Effective on August 15, 2024, the Board of Directors of Avnet, Inc. (the “Company”) elected Virginia L. Henkels and Helmut Gassel to serve as directors of the Company.
Effective on August 15, 2024, the Board of Directors of Avnet, Inc. (the “Company”) elected Virginia L. Henkels and Helmut Gassel to serve as directors of the Company.
On August 13, 2024, Dr. Marschall S. Runge notified the Board of Directors (the "Board") of Eli Lilly and Company (the "Company") of his decision to retire from the Board, effective as of August 31, 2024.
On August 15, 2024, the Board of Directors (the “Board”) of Sysco Corporation (“Sysco” or the “Company”) increased the size of the Board from ten to eleven directors and elected Mr. Roberto Marques to fill the resulting vacancy, effective on August 15, 2024.
On August 15, 2024, Jim Hinrichs, a member of the Board of Directors (the “Board”) of Outset Medical, Inc. (the “Company”), notified the Company of his decision to resign from the Board and his role as Audit Committee Chair, effective immediately.
On August 12, 2024, Jill Bright was appointed to the Board of Directors (the “Board”) of Viad Corp (the “Company”).
On August 13, 2024, the board of directors (the “Board”) of Seer, Inc. (the “Company”) appointed Nicolas Henry Roelofs, Ph.D. to the Board with a term expiring at the Company’s 2025 annual meeting of the stockholders.
The Company also announced that Dr. Roelofs would replace David Hallal as the Company’s Lead Independent Director and would serve on the Company’s Corporate Governance and Nominating Committee and Science and Technology Committee.
The Board of Directors (the “ Board ”) of the Company appointed Pablo Barahona as an independent director of the Company, effective August 12, 2024.
Director Ranson W. Webster, announcing that Mr. Webster would retire and withdraw as a director of the Company effective as of October 1, 2024.
Michael (Mike) S. Curless, former Chief Investment Officer and Chief Customer Officer for Prologis
Carl J. (Rick) Rickertsen, Managing Partner of Pine Creek Partners and current director of Berry
Thomas M. Fahnemann, current director and President & Chief Executive Officer of Glatfelter
Samantha (Sam) J. Marnick, former Chief Operating Officer, President Commercial for Spirit AeroSystems
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Bruce Brown, former Chief Technology Officer for Procter & Gamble and current director of Glatfelter
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Thomas (Tom) E. Salmon, former Chief Executive Officer and Chairman of Berry
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Kathleen A. Dahlberg, Marie T. Gallagher, Darrel Hackett and J. Robert Hall will retire from the Glatfelter board upon the Closing.
Effective August 12, 2024, the Board of Directors (the “Board”) of Mastech Digital, Inc. (the “Company”) increased the size of the Board to nine members and appointed Srinivas Kandula, Arun Nayar and Bonnie K. Smith as independent members of the Board.
Effective August 12, 2024, the Board of Directors (the “Board”) of Mastech Digital, Inc. (the “Company”) increased the size of the Board to nine members and appointed Srinivas Kandula, Arun Nayar and Bonnie K. Smith as independent members of the Board.
Effective August 12, 2024, the Board of Directors (the “Board”) of Mastech Digital, Inc. (the “Company”) increased the size of the Board to nine members and appointed Srinivas Kandula, Arun Nayar and Bonnie K. Smith as independent members of the Board.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Gordon J. Brooks, Michael C. Thompson and Christopher Anderson, each a director of Purchaser immediately prior to the Effective Time, became directors of the Company, in each case, effective as of the Effective Time.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Gordon J. Brooks, Michael C. Thompson and Christopher Anderson, each a director of Purchaser immediately prior to the Effective Time, became directors of the Company, in each case, effective as of the Effective Time.
Gordon J. Brooks, Michael C. Thompson and Christopher Anderson, each a director of Purchaser immediately prior to the Effective Time, became directors of the Company, in each case, effective as of the Effective Time.
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Gustav Christensen, Timothy A. Springer, Ph.D., Norbert Bischofberger, Ph.D., Martin Edwards, Susannah Gray, Nisha Nanda, Ph.D, Amir Nashat, Sc.D., Joseph P. Slattery, and Praveen P. Tipirneni, M.D. resigned from his or her respective position as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
On August 15, 2024, ResMed Inc. appointed Christopher DelOrefice to serve on its board of directors, with a term expiring at ResMed’s 2024 annual meeting of stockholders on November 21, 2024
On August 12, 2024, James Vance notified the Board of Directors (the “Board”) of the Company of his resignation as a member of the Board, effective as of such date.
each of Cathy Jiang and Brian Hartzband resigned as directors
each of Cathy Jiang and Brian Hartzband resigned as directors
On August 14, 2024, Punit Dhillon notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 14, 2024.
Eren Bali resigned from the Board of Directors (the "Board") of Udemy, Inc. (the "Company") and its committees
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
On August 13, 2024, the Board of Directors (the “Board”) of Deluxe Corporation (the “Company”) unanimously elected Angela L. Brown to the Board to serve for a term ending at the 2025 Annual Meeting of the Shareholders.
appointed Michael S. Della Rocca and Marian M. Durkin to the Board, in each case, effective August 15, 2024, to serve until the 2025 Annual Meeting of Stockholders.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.